A Clinical Debate: What Is the Therapeutic Choice for Recurrent Graves' Hyperthyroidism?
作者信息
Abdi Hengameh, Zakavi Seyed Rasoul, Azizi Fereidoun
机构信息
Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
出版信息
Int J Endocrinol Metab. 2020 Oct 31;18(4):e108876. doi: 10.5812/ijem.108876. eCollection 2020 Oct.
Abstract
摘要
相似文献
1
A Clinical Debate: What Is the Therapeutic Choice for Recurrent Graves' Hyperthyroidism?一场临床辩论：复发性格雷夫斯甲亢的治疗选择是什么？
Int J Endocrinol Metab. 2020 Oct 31;18(4):e108876. doi: 10.5812/ijem.108876. eCollection 2020 Oct.
2
[Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].[放射性碘与手术治疗格雷夫斯病甲亢的对比]
Lijec Vjesn. 2010 Nov-Dec;132(11-12):355-60.
3
Management of Graves' hyperthyroidism: present and future.格雷夫斯病甲亢的管理：现状与未来。
Expert Rev Endocrinol Metab. 2022 Mar;17(2):153-166. doi: 10.1080/17446651.2022.2052044. Epub 2022 Mar 14.
4
Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.甲状腺次全切除术后格雷夫斯病患者复发性甲状腺功能亢进症的管理。
J Endocrinol Invest. 1995 Jun;18(6):415-9. doi: 10.1007/BF03349738.
5
Long-term follow-up result of antithyroid drug treatment of Graves' hyperthyroidism in a large cohort.大样本 Graves 病甲亢抗甲状腺药物治疗的长期随访结果。
Eur Thyroid J. 2023 Mar 17;12(2). doi: 10.1530/ETJ-22-0226. Print 2023 Apr 1.
6
[Hyperthyroidism in Graves' disease--antithyroid drug treatment].[格雷夫斯病中的甲状腺功能亢进——抗甲状腺药物治疗]
Z Arztl Fortbild Qualitatssich. 1999 Apr;93 Suppl 1:41-5.
7
Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.Graves 病的主要治疗方法与心血管发病率和死亡率：一项关联记录队列研究。
Lancet Diabetes Endocrinol. 2019 Apr;7(4):278-287. doi: 10.1016/S2213-8587(19)30059-2. Epub 2019 Feb 28.
8
Non-thionamide antithyroid drug options in Graves' hyperthyroidism.Graves 病甲亢的非硫脲类抗甲状腺药物选择。
Expert Rev Endocrinol Metab. 2023 Jan;18(1):67-79. doi: 10.1080/17446651.2023.2167709. Epub 2023 Feb 5.
9
Efficacy of radioactive iodine treatment of graves' hyperthyroidism using a single calculated I dose.使用单次计算碘剂量进行放射性碘治疗格雷夫斯病甲亢的疗效
Clin Diabetes Endocrinol. 2018 Nov 28;4:20. doi: 10.1186/s40842-018-0071-6. eCollection 2018.
10
Long-term remission following antithyroid drug withdrawal in patients with Graves' hyperthyroidism: parameters with prognostic value.Graves 甲亢患者停用抗甲状腺药物后的长期缓解：具有预后价值的参数。
Endocrine. 2019 Feb;63(2):316-322. doi: 10.1007/s12020-018-1785-z. Epub 2018 Oct 17.
引用本文的文献
1
Characteristics of thyrotoxicosis among thyroid patients and their quality of life in a teaching hospital in Jordan: A cross-sectional study.约旦一家教学医院甲状腺疾病患者的甲状腺毒症特征及其生活质量：一项横断面研究。
Pharm Pract (Granada). 2022 Jan-Mar;20(1):2586. doi: 10.18549/PharmPract.2022.1.2586. Epub 2022 Jan 17.
2
Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves' disease: a systematic scoping review.抗甲状腺药物治疗的适当疗程作为Graves病复发的预测指标：一项系统综述
J Endocrinol Invest. 2022 Jun;45(6):1139-1150. doi: 10.1007/s40618-021-01730-1. Epub 2022 Jan 28.
本文引用的文献
1
Antithyroid Drugs.抗甲状腺药物
Iran J Pharm Res. 2019 Fall;18(Suppl1):1-12. doi: 10.22037/ijpr.2020.112892.14005.
2
Effect of Different 131I Dose Strategies for Treatment of Hyperthyroidism on Graves' Ophthalmopathy.不同 131I 剂量方案治疗甲亢对格雷夫斯眼病的影响。
Clin Nucl Med. 2020 Jul;45(7):514-518. doi: 10.1097/RLU.0000000000003086.
3
Improving treatment outcomes for Graves' disease patients with inactive forms of Graves' orbitopathy through an increased dose of radioiodine therapy.通过增加放射性碘治疗剂量改善 Graves 眼病无活动期 Graves 病患者的治疗结局。
Nuklearmedizin. 2020 Jun;59(3):260-268. doi: 10.1055/a-1149-8552. Epub 2020 May 13.
4
Toward Ultimate Care for Graves' Hyperthyroidism.迈向格雷夫斯病甲亢的终极治疗
Int J Endocrinol Metab. 2019 Nov 2;18(1):e98255. doi: 10.5812/ijem.98255. eCollection 2020 Jan.
5
Long-Term Treatment of Hyperthyroidism with Antithyroid Drugs: 35 Years of Personal Clinical Experience.抗甲状腺药物治疗甲状腺功能亢进症的长期治疗：35年个人临床经验
Thyroid. 2020 Oct;30(10):1451-1457. doi: 10.1089/thy.2019.0814. Epub 2020 May 11.
6
Should radioiodine now be first line treatment for Graves' disease?放射性碘现在应该成为格雷夫斯病的一线治疗方法吗？
Thyroid Res. 2020 Mar 9;13:3. doi: 10.1186/s13044-020-00077-8. eCollection 2020.
7
Systemic Thyroid Hormone Status in Treated Graves' Disease.治疗后格雷夫斯病患者的全身甲状腺激素状态
Int J Endocrinol Metab. 2019 Oct 12;17(4):e95385. doi: 10.5812/ijem.95385. eCollection 2019 Oct.
8
Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.Graves 病患者治疗选择的使用模式、疗效和安全性：一项全国范围内基于人群的研究。
Thyroid. 2020 Mar;30(3):357-364. doi: 10.1089/thy.2019.0132. Epub 2020 Feb 26.
9
Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism: A Cohort Study.放射性碘治疗甲状腺功能亢进后癌症风险：一项队列研究。
Thyroid. 2020 Feb;30(2):243-250. doi: 10.1089/thy.2019.0205. Epub 2020 Jan 23.
10
Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study.放射性碘消融治疗 Graves 病患者中短期口服或静脉类固醇预防眶病的前瞻性随机对照试验研究。
Thyroid. 2019 Dec;29(12):1828-1833. doi: 10.1089/thy.2019.0150.
Zotero 插件